{"id":"https://openalex.org/W4310106205","doi":"https://doi.org/10.1182/blood-2022-162707","title":"Prevalence of Clonal Hematopoiesis of Indeterminate Potential in Patients with Monoclonal B-Cell Lymphocytosis Compared to Untreated Chronic Lymphocytic Leukemia","display_name":"Prevalence of Clonal Hematopoiesis of Indeterminate Potential in Patients with Monoclonal B-Cell Lymphocytosis Compared to Untreated Chronic Lymphocytic Leukemia","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310106205","doi":"https://doi.org/10.1182/blood-2022-162707"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-162707","doi":"https://doi.org/10.1182/blood-2022-162707","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-162707","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063792058","display_name":"Anisha V. Patel","orcid":"https://orcid.org/0009-0000-7004-4218","observed_orcids":["https://orcid.org/0009-0000-7004-4218"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anisha V. Patel","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068150481","display_name":"Abirami Vijenthira","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abirami Vijenthira","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087340009","display_name":"Aswin Sekar","orcid":"https://orcid.org/0000-0003-0406-0935","observed_orcids":["https://orcid.org/0000-0003-0406-0935"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aswin Sekar","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050468541","display_name":"Christopher James Gibson","orcid":"https://orcid.org/0000-0002-3700-5310","observed_orcids":["https://orcid.org/0000-0002-3700-5310"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher J. Gibson","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087910671","display_name":"Stephen P. Martindale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen P. Martindale","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004620459","display_name":"Rayan Fardoun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rayan Fardoun","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010499534","display_name":"Svitlana Tyekucheva","orcid":"https://orcid.org/0000-0002-3119-6507","observed_orcids":["https://orcid.org/0000-0002-3119-6507"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Svitlana Tyekucheva","raw_affiliation_strings":["2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009506175","display_name":"Stacey M. Fernandes","orcid":"https://orcid.org/0000-0002-5061-5199","observed_orcids":["https://orcid.org/0000-0002-5061-5199"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacey M. Fernandes","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059452140","display_name":"Binyamin A. Knisbacher","orcid":"https://orcid.org/0000-0002-4962-9956","observed_orcids":["https://orcid.org/0000-0002-4962-9956"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Binyamin A. Knisbacher","raw_affiliation_strings":["3Broad Institute of MIT and Harvard, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029365172","display_name":"Cynthia K. Hahn","orcid":"https://orcid.org/0000-0001-8284-7261","observed_orcids":["https://orcid.org/0000-0001-8284-7261"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia K. Hahn","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001392592","display_name":"Gad A. Getz","orcid":"https://orcid.org/0000-0002-0936-0753","observed_orcids":["https://orcid.org/0000-0002-0936-0753"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gad Getz","raw_affiliation_strings":["3Broad Institute of MIT and Harvard, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Broad Institute of MIT and Harvard, Cambridge, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047701430","display_name":"Catherine J. Wu","orcid":"https://orcid.org/0000-0002-3348-5054","observed_orcids":["https://orcid.org/0000-0002-3348-5054"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine J. Wu","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063755644","display_name":"Matthew Steven Davids","orcid":"https://orcid.org/0000-0003-4529-2003","observed_orcids":["https://orcid.org/0000-0003-4529-2003"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew S. Davids","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016570475","display_name":"Jennifer R. Brown","orcid":"https://orcid.org/0000-0003-2040-4961","observed_orcids":["https://orcid.org/0000-0003-2040-4961"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer R. Brown","raw_affiliation_strings":["1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.21687302,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"140","issue":"Supplement 1","first_page":"7038","last_page":"7040"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.022199999541044235,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clonal-hematopoiesis-of-indeterminate-potential","display_name":"clonal hematopoiesis of indeterminate potential","score":0.9959999918937683},{"id":"https://openalex.org/keywords/monoclonal-b-cell-lymphocytosis","display_name":"monoclonal B-cell lymphocytosis","score":0.9829999804496765},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.8240000009536743},{"id":"https://openalex.org/keywords/ighv-mutation-status","display_name":"IGHV mutation status","score":0.7080000042915344},{"id":"https://openalex.org/keywords/tp53","display_name":"TP53","score":0.44999998807907104},{"id":"https://openalex.org/keywords/sf3b1","display_name":"SF3B1","score":0.9200000166893005},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.4090000092983246},{"id":"https://openalex.org/keywords/sf3b1-mutation","display_name":"SF3B1 mutation","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7663141489028931},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.7292984127998352},{"id":"https://openalex.org/C2780126324","wikidata":"https://www.wikidata.org/wiki/Q612345","display_name":"Lymphocytosis","level":2,"score":0.7022483348846436},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5882510542869568},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5832559466362},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4654766917228699},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45342373847961426},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4036717712879181},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3986018896102905},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3938947021961212},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3402385115623474},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0667944848537445}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-162707","doi":"https://doi.org/10.1182/blood-2022-162707","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-162707","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7204735289","https://openalex.org/W4402560902","https://openalex.org/W4417017800","https://openalex.org/W4400109290","https://openalex.org/W4402824677","https://openalex.org/W2922014345","https://openalex.org/W4415964927","https://openalex.org/W2557993213","https://openalex.org/W2552328330","https://openalex.org/W2259604859"],"abstract_inverted_index":{"Background:":[0],"Monoclonal":[1],"B-cell":[2],"lymphocytosis":[3],"(MBL)":[4],"is":[5,21,700,709],"a":[6,146,162,172,186,229,392,567,578,604,618,653],"benign":[7],"precursor":[8],"condition":[9,24],"to":[10,100,116,127,138,286,296,372,471,549,554,588,603,674,716],"chronic":[11],"lymphocytic":[12],"leukemia":[13],"(CLL).":[14],"Clonal":[15],"hematopoiesis":[16],"of":[17,28,45,64,73,83,131,188,255,283,302,333,357,396,461,493,520,571,607,628,657],"indeterminate":[18],"potential":[19],"(CHIP)":[20],"an":[22,276,563],"age-related":[23],"characterized":[25],"by":[26],"accumulation":[27],"somatic":[29],"mutations":[30,119,375,397,408,437,552],"in":[31,41,54,62,95,133,161,210,232,245,257,310,410,422,439,451,501,600,633,639,690,702],"the":[32,42,46,129,240,253,288,387,404,417,433,446,489,517,626,688],"blood.":[33,43],"Both":[34],"conditions":[35],"involve":[36],"low":[37,605],"level":[38],"clonal":[39],"populations":[40],"Review":[44],"literature":[47],"identified":[48],"one":[49],"prior":[50],"abstract":[51],"evaluating":[52],"CHIP":[53,61,90,113,118,291,576],"patients":[55,66,75,96,134,139,151,156,258,264,321,337,358,368,401,429,467,472,502,521,540,543,555,634,640,680,694,706],"with":[56,67,76,97,135,140,152,157,259,322,338,363,402,430,468,473,503,522,524,541,544,556,566,584,635,641,669,681,695,707],"MBL.":[57],"This":[58,596,686],"study":[59,148],"found":[60,624],"17%":[63],"251":[65],"CLL":[68,101,159,164,211,246,263,326,342,367,475,506,528,557,589,643,663,670,676],"(median":[69,78,87],"age":[70,79,88,311,330,519],"63),":[71],"12%":[72],"74":[74],"MBL":[77,98,136,153,260,295,323,339,364,469,504,525,545,587,636,708],"61.5),":[80],"and":[81,154,201,292,318,349,365,390,413,416,425,442,445,456,611,666,697,713],"8%":[82],"246":[84],"unaffected":[85],"relatives":[86],"54).":[89],"was":[91,126,343,463,496,529,581,598,630],"not":[92,582,649],"more":[93,208,490,499,547,654,660,672,718],"common":[94,209,406,419,435,448,500],"compared":[99,137,470,553],"(Boddicker.":[102],"Blood.":[103],"2018;132(S1):":[104],"3116).":[105],"In":[106,225,299,562],"this":[107,646,684],"study,":[108],"we":[109,234,487,623],"focused":[110],"on":[111,196,386],"myeloid":[112,712],"(M-CHIP)":[114],"specifically,":[115],"distinguish":[117],"from":[120,281,294,586,705],"MBL/CLL":[121],"related":[122],"mutations.":[123],"Our":[124],"objective":[125],"characterize":[128],"prevalence":[130,460,627],"M-CHIP":[132,190,197,213,256,462,523,629,658,691],"untreated":[141,158,262,325,341,366,431,474,527,642],"CLL.":[142,297],"Methods:":[143],"We":[144,184,227,251,273],"performed":[145,179,228,275],"retrospective":[147],"including":[149],"44":[150],"749":[155],"enrolled":[160],"prospective":[163],"biobank":[165],"at":[166,312,331],"Dana-Farber":[167],"Cancer":[168],"Institute":[169],"who":[170],"had":[171,391],"95-gene":[173],"targeted":[174],"next-generation":[175],"sequencing":[176],"(NGS)":[177],"panel":[178,285,335],"(J":[180],"Mol":[181],"Diagn.":[182],"2016;18:507).":[183],"created":[185],"list":[187],"56":[189],"candidate":[191],"genes":[192,205,238,244,665,678],"using":[193,265,617,652],"published":[194],"criteria":[195],"(Nat":[198],"Med.":[199],"2021;27:1921)":[200],"excluded":[202,236],"8":[203],"overlap":[204,237,661],"that":[206,625],"were":[207,306,359,369,409,421,438,450,546],"than":[212,505,638,679],"(SF3B1,":[214],"TP53,":[215],"BRAF,":[216],"KRAS,":[217],"BCOR,":[218],"NRAS,":[219],"CREBBP,":[220],"SETD2;":[221],"Knisbacher.":[222],"Nat":[223],"Genetics.":[224],"press).":[226],"sensitivity":[230],"analysis":[231,280,565,597],"which":[233,703],"only":[235,248],"among":[239,466],"top":[241],"5":[242],"driver":[243,664,677],"(specifically,":[247],"SF3B1,":[249],"TP53).":[250],"analyzed":[252],"association":[254,647],"vs.":[261,324,340,355,377,383,477,508,526,534,559],"logistic":[266],"regression":[267],"controlling":[268],"for":[269,320,336,621,693],"IGHV":[270],"mutational":[271],"status.":[272],"also":[274],"exploratory":[277,564],"landmark":[278],"survival":[279],"time":[282,332,570],"NGS":[284,315,334,388],"assess":[287],"relationship":[289],"between":[290,662],"progression":[293,585,608],"Results:":[298],"our":[300],"cohort":[301],"793":[303],"patients,":[304],"there":[305],"no":[307,497],"significant":[308],"differences":[309],"diagnosis":[313],"or":[314,380],"panel,":[316,389],"sex,":[317],"cytogenetics,":[319],"(Table":[327,398],"1).":[328,399],"Median":[329],"65":[344],"(interquartile":[345],"range":[346],"(IQR)":[347],"60-71)":[348],"64":[350],"(IQR":[351,532,536,574],"57-72)":[352],"respectively.":[353,361],"43%":[354],"40%":[356],"female,":[360],"Patients":[362,668],"equally":[370],"likely":[371,548,673],"have":[373,550,675],"pathogenic":[374,407,436],"(50%":[376],"60%,":[378],"p=0.2)":[379],"VUS":[381,420,449],"(70%":[382],"77%,":[384],"p=0.3)":[385],"similar":[393,530],"total":[394],"number":[395,606],"Among":[400,428,539],"MBL,":[403,682],"most":[405,418,434,447],"DNMT3A":[411,551],"(27%)":[412],"NOTCH1":[414,440],"(9%)":[415],"ATM":[423,452],"(18%)":[424],"BCOR":[426],"(14%).":[427],"CLL,":[432],"(15%)":[441],"SF3B1":[443],"(13%)":[444],"(17%),":[453],"CREBBP":[454],"(6%),":[455],"TET2":[457],"(6%).":[458],"The":[459],"significantly":[464,631],"greater":[465,632],"(23%":[476],"12%,":[478],"OR":[479,510],"2.2,":[480],"95%":[481,512,592],"CI":[482,513,593],"1.1-4.7,":[483],"p=0.034).":[484],"However,":[485,645],"when":[486,651],"used":[488],"sensitive":[491,655],"definition":[492,620,656],"M-CHIP,":[494,542,622],"it":[495],"longer":[498],"(25%":[507],"18%,":[509],"1.7,":[511],"0.8-2.2,":[514],"p=0.15).":[515],"Notably,":[516],"median":[518,568],"(70":[531],"65-74)":[533],"67":[535],"61-74)":[537],"(p=0.53)).":[538],"(100%":[558],"46%,":[560],"p=0.001).":[561],"follow-up":[569,613],"152":[572],"days":[573],"28-639),":[575],"as":[577],"binary":[579],"predictor":[580],"associated":[583],"(HR":[590],"0.9,":[591],"0.2-4.4,":[594],"p=0.9).":[595],"limited":[599,612],"power":[601],"due":[602],"events":[609],"(N=9)":[610],"duration.":[614],"Conclusions:":[615],"When":[616],"strict":[619],"(23%)":[637],"(12%).":[644],"did":[648],"persist":[650],"allowing":[659],"M-CHIP.":[667],"are":[671],"explaining":[683],"discrepancy.":[685],"illustrates":[687],"challenges":[689],"categorization":[692],"MBL/CLL,":[696],"further":[698],"research":[699],"ongoing":[701],"blood":[704],"sorted":[710],"into":[711],"lymphoid":[714],"compartments":[715],"allow":[717],"definite":[719],"categorization.":[720],"Figure":[721],"1View":[722,725],"largeDownload":[723,726],"PPTFigure":[724],"PPT":[727],"Close":[728],"modal":[729]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-11-30T00:00:00"}